Cutaneous Melanoma, Stage III
7 clinical trials · Condition
◉ Watch Cutaneous Melanoma, Stage III
| Record | Firm | Date |
|---|---|---|
| Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy (NCT03719131) | Emory University | 2019-06-05 |
| pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma (NCT03655756) | TuHURA Biosciences, Inc. | 2018-11-05 |
| Evaluation of Oncoxin-Viusid® in Cutaneous Melanoma (NCT03541148) | Catalysis SL | 2014-09-16 |
| IFx-Hu2.0 Expanded Access Program (NCT04853602) | TuHURA Biosciences, Inc. |
Track Cutaneous Melanoma, Stage III automatically
Every clearance here is in the API, with alerts when new ones post.